C141H140F3N43O13 — CID 157152889
2-[4-(3,6-dihydro-2H-pyran-4-yl)-2,5-dimethylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-2-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-5-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide (PubChem CID 157152889) has the molecular formula C141H140F3N43O13 and a molecular weight of 2701.95 g/mol. Its IUPAC name is 2-[4-(3,6-dihydro-2H-pyran-4-yl)-2,5-dimethylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-2-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-5-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide.
| Compound Name | 2-[4-(3,6-dihydro-2H-pyran-4-yl)-2,5-dimethylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-2-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-5-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide |
|---|---|
| PubChem CID | 157152889 |
| Molecular Formula | C141H140F3N43O13 |
| Molecular Weight | 2701.95 g/mol |
| Exact Mass | 2700.16 |
| IUPAC Name | 2-[4-(3,6-dihydro-2H-pyran-4-yl)-2,5-dimethylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-2-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(3,6-dihydro-2H-pyran-4-yl)-5-methylimidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide |
| SMILES | Cc1c(C2=CCOCC2)ncn1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1c(C2CCOCC2)ncn1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1nc(-c2ccc(C(F)(F)F)nc2)cn1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1nc(C2=CCOCC2)c(C)n1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1nc(C2=CCOCC2)cn1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1nc(C2CCOCC2)cn1CC(=O)Nc1ccc(-c2cnccn2)cn1.O=C(Cn1cnc(C2=CCOCC2)c1)Nc1ccc(-c2cnccn2)cn1 |
| InChI | InChI=1S/C21H16F3N7O.C21H22N6O2.C20H22N6O2.C20H20N6O2.C20H22N6O2.C20H20N6O2.C19H18N6O2/c1-13-29-17(15-2-4-18(27-8-15)21(22,23)24)11-31(13)12-20(32)30-19-5-3-14(9-28-19)16-10-25-6-7-26-16;1-14-21(16-5-9-29-10-6-16)25-15(2)27(14)13-20(28)26-19-4-3-17(11-24-19)18-12-22-7-8-23-18;2*1-14-24-18(15-4-8-28-9-5-15)12-26(14)13-20(27)25-19-3-2-16(10-23-19)17-11-21-6-7-22-17;2*1-14-20(15-4-8-28-9-5-15)24-13-26(14)12-19(27)25-18-3-2-16(10-23-18)17-11-21-6-7-22-17;26-19(12-25-11-17(23-13-25)14-3-7-27-8-4-14)24-18-2-1-15(9-22-18)16-10-20-5-6-21-16/h2-11H,12H2,1H3,(H,28,30,32);3-5,7-8,11-12H,6,9-10,13H2,1-2H3,(H,24,26,28);2-3,6-7,10-12,15H,4-5,8-9,13H2,1H3,(H,23,25,27);2-4,6-7,10-12H,5,8-9,13H2,1H3,(H,23,25,27);2-3,6-7,10-11,13,15H,4-5,8-9,12H2,1H3,(H,23,25,27);2-4,6-7,10-11,13H,5,8-9,12H2,1H3,(H,23,25,27);1-3,5-6,9-11,13H,4,7-8,12H2,(H,22,24,26) |
| InChIKey | ALLQHIVAJJHXTF-UHFFFAOYSA-N |
| XLogP | 18.86 |
| TPSA | 667.40 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 49 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 200 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2701.95 |
| LogP ≤ 5 | 18.86 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 49 |